Nordin Noorfariza, Yaacob Najib Majdi, Abdullah Noor Hashimah, Mohd Hairon Suhaily
Department of Community Medicine, School of Medical Sciences, Universiti Sains, Malaysia. Email:
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):497-502. doi: 10.22034/APJCP.2018.19.2.497.
Background: Breast cancer is the most common malignant disease and the leading cause of cancer death among women globally. This study aimed to determine the median survival time and prognostic factors for breast cancer patients in a North-East State of Malaysia. Methods: This retrospective cohort study was conducted from January till April 2017 using secondary data obtained from the state’s cancer registry. All 549 cases of breast cancer diagnosed from 1st January 2007 until 31st December 2011 were selected and retrospectively followed-up until 31st December 2016. Sociodemographic and clinical information was collected to determine prognostic factors. Results: The average (SD) age at diagnosis was 50.4 (11.2) years, the majority of patients having Malay ethnicity (85.8%) and a histology of ductal carcinoma (81.5%). Median survival times for those presenting at stages III and IV were 50.8 (95% CI: 25.34, 76.19) and 6.9 (95% CI: 3.21, 10.61) months, respectively. Ethnicity (Adj. HR for Malay vs non-Malay ethnicity=2.52; 95% CI: 1.54, 4.13; p<0.001), stage at presentation (Adj. HR for Stage III vs Stage I=2.31; 95% CI: 1.57, 3.39; p<0.001 and Adj. HR for Stage IV vs Stage I=6.20; 95% CI: 4.45, 8.65; p<0.001), and history of surgical treatment (Adj. HR for patients with no surgical intervention=1.95; 95% CI: 1.52, 2.52; p<0.001) were observed to be the statistically significant prognostic factors associated with death caused by breast cancer. Conclusion: The median survival time among breast cancer patients in North-East State of Malaysia was short as compared to other studies. Primary and secondary prevention aimed at early diagnosis and surgical management of breast cancer, particularly among the Malay ethnic group, could improve treatment outcome.
乳腺癌是全球女性中最常见的恶性疾病及癌症死亡的主要原因。本研究旨在确定马来西亚东北部一个州乳腺癌患者的中位生存时间及预后因素。方法:本回顾性队列研究于2017年1月至4月进行,使用从该州癌症登记处获得的二手数据。选取2007年1月1日至2011年12月31日期间诊断的所有549例乳腺癌病例,并对其进行回顾性随访直至2016年12月31日。收集社会人口统计学和临床信息以确定预后因素。结果:诊断时的平均(标准差)年龄为50.4(11.2)岁,大多数患者为马来族裔(85.8%),组织学类型为导管癌(81.5%)。III期和IV期患者的中位生存时间分别为50.8(95%置信区间:25.34,76.19)个月和6.9(95%置信区间:3.21,10.61)个月。种族(马来族与非马来族裔的调整后风险比=2.52;95%置信区间:1.54,4.13;p<0.001)、就诊时的分期(III期与I期的调整后风险比=2.31;95%置信区间:1.57,3.39;p<0.001以及IV期与I期的调整后风险比=6.20;95%置信区间:4.45,8.65;p<0.001)和手术治疗史(未进行手术干预患者的调整后风险比=1.95;95%置信区间:1.52,2.52;p<0.001)被观察到是与乳腺癌死亡相关的具有统计学意义的预后因素。结论:与其他研究相比,马来西亚东北部州乳腺癌患者的中位生存时间较短。针对乳腺癌的早期诊断和手术管理的一级和二级预防,特别是在马来族裔群体中,可以改善治疗结果。